Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GL Biochem (Shanghai) is a leading international contract research organization (CRO) and manufacturer specializing in peptide synthesis and related biochemical products. Founded in 1998 and headquartered in Shanghai, the company provides a comprehensive suite of services including custom peptide synthesis, large-scale manufacturing, and the production of amino acid derivatives. With a workforce of over 1,000 employees and extensive laboratory facilities, GL Biochem serves a global clientele across the pharmaceutical, biotechnology, and academic sectors. Their technical capabilities encompass complex modifications such as phosphorylation, cyclization, and the production of peptidomimetics. The company is recognized as one of the largest and most prolific peptide suppliers in the world, supporting drug discovery from early research through to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai GL Peptide.